2026-11-16 10:39Pressrelease

Nil Medical recruits Head of Sales and names Malin Walfridsson as CEO

Sammy, Malin and Martin together. Malin in the middle, holding a Vestpack. The expanded Nil Medical team from the left: Sammy Malca, Head of Sales, Malin Walfridsson, CEO, and Martin Hanberger, founder.

Vestpack, an infusion vest designed to give children greater freedom of movement during hospital treatment, is now used in hospitals across several European countries and is being evaluated in additional markets. To meet growing interest, Swedish medtech company Nil Medical is strengthening its team. Sammy Malca joins as Head of Sales, Malin Walfridsson takes over as CEO, and founder Martin Hanberger shifts his focus towards innovation and strategic partnerships.

Malin Walfridsson joined Nil Medical as Chief Operating Officer last summer and has served as Acting CEO for the past six months. She now formally succeeds founder Martin Hanberger as CEO and will lead the company's next phase of development.

“We have a fantastic product in Vestpack, and our priority now is to make it available to more children who could benefit from it. At the same time, we need to build a company that is sustainable in the long term and allows us to continue developing and growing,” says Malin Walfridsson, who holds a PhD in medicinal chemistry and has more than ten years of experience in various roles across the life sciences sector.

Expanding the sales team to reach more patients
Nil Medical currently has paying customers in Sweden, Finland and the UK, while Vestpack is being evaluated in around ten countries across Europe and the Middle East.

“We receive incredibly positive feedback on Vestpack from both families and healthcare professionals, and we are constantly working to make it available to as many children as possible during their treatment. To accelerate these efforts, while also creating opportunities to develop additional products for people undergoing demanding medical treatments, we need to expand our team,” says Malin Walfridsson.

As part of this expansion, Sammy Malca will join Nil Medical as Head of Sales on 1 December. He joins from Eltel Networks and brings extensive experience in international sales, including a previous role as Nordic Sales Manager at medtech company ConvaTec.

“Nil Medical is a company that genuinely cares about making a difference. If we can make life easier for children, that is something truly meaningful. I see tremendous potential in Vestpack, and working in a smaller company means shorter decision-making processes, allowing us to move quickly and make the most of that potential,” says Sammy Malca.

“We are delighted to welcome Sammy to the team. His extensive experience in medical device sales and his close relationships with healthcare providers will be invaluable as we work to give more people greater freedom during treatment,” says Malin Walfridsson.

Potential for new patient groups and applications
Martin Hanberger first began developing the infusion vest now known as Vestpack as part of his degree project at Umeå Institute of Design in 2011. He has served as CEO of Nil Medical since the company was established six years ago, but will now focus more on innovation and strategic partnerships.

“As we scale up, we want to optimise how we organise our team. We see significant potential to develop Vestpack for additional patient groups and applications, driven both by needs identified in healthcare and ideas emerging within the company. This is something I am truly passionate about, and with Malin taking over as CEO, I will be able to devote even more time to innovation,” says Martin Hanberger.

About Nil Medical
• Nil Medical is a Swedish medtech company based in Umeå that develops and sells Vestpack, an infusion vest designed to give children greater freedom of movement during hospital treatment.
• Vestpack uses padded materials and integrated safety features to protect infusion fluids, pumps, and tubing inside the vest.
• The company has paying customers in Sweden, Finland and the UK and is working to introduce Vestpack in additional international markets.
• Barncancerfonden Impact Invest, the investment arm of the Swedish Childhood Cancer Fund, is among the company's shareholders.
• Nil Medical receives business development support from Umeå Biotech Incubator. 

For more info, contact: 
Malin Walfridsson, CEO, Nil Medical
Tel: +46(0)730443450
Email: malin.walfridsson@nilmedical.com



About Umeå Biotech Incubator

Umeå Biotech Incubator (UBI) is one of Sweden’s state-of-the-art business incubators within the life sciences. We help researchers to use their data to the benefit of patients and citizens, improving their health. We support and train entrepreneurs in the fields of pharmaceuticals, diagnostics and medical engineering, and act as a bridge between academia, medicine and the business community.


Contacts

Tomas Ruuth
Head of PR & Communications
Tomas Ruuth